SRTS · Sensus Healthcare, Inc.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
Cap structure and valuation
| Cap structure | |
|---|---|
| SP | $3.56 |
| SO | 16.5M |
| Options | 0.1M |
| Warrants | 0.1M |
| FD SO | 16.7M |
| MC | $59.4M |
| Cash | $15.2M |
| Total debt | — |
| EV | $44.2M |
| TTM Multiples | |
|---|---|
| EV / Revenue | 2.5x |
| EV / EBITDA | — |
| MC / Net Income | — |
| EV / FCF | — |
| MC / FCF | — |
| Ownership & coverage | |
|---|---|
| Institutional | 26.8% |
| Insiders | 18.1% |
| # Institutions | 53 |
| Analysts | 4 |
| Consensus | Strong Buy |
| Avg target | $5.38 |
| Short % float | 1.4% |
| Days to cover | 10.07 |
MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-08-10. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-09-01 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-08-14; the float denominator can be unreliable on tiny floats.
Financial statements
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Total Revenue | 2.29 | 3.39 | 4.94 | 6.88 |
| Revenue YoY % | (68.7%) | (59.3%) | (62.2%) | (22.1%) |
| Cost of Revenue | 1.52 | 2.40 | 3.04 | 4.17 |
| Gross Profit | 0.77 | 0.99 | 1.90 | 2.71 |
| Gross Profit YoY % | (73.5%) | (77.2%) | (73.3%) | (48.2%) |
| Gross Margin % | 33.6% | 29.2% | 38.4% | 39.4% |
| SG&A | 1.79 | 2.04 | 1.76 | 1.92 |
| R&D | 1.11 | 1.59 | 1.88 | 1.82 |
| Operating Expense | 3.95 | 5.35 | 5.04 | 5.28 |
| Operating Income | (3.18) | (4.36) | (3.15) | (2.57) |
| Operating Income YoY % | (63.7%) | (64.7%) | (282.4%) | (271.8%) |
| Operating Margin % | (138.9%) | (128.4%) | (63.7%) | (37.3%) |
| EBITDA | (3.09) | (4.26) | (3.04) | (2.47) |
| EBITDA Margin % | (135.1%) | (125.6%) | (61.7%) | (35.9%) |
| Interest Expense | 0.12 | 0.12 | 0.15 | 0.16 |
| Pretax Income | (3.06) | (4.23) | (2.99) | (2.41) |
| Tax Provision | 5.69 | (1.61) | 0.17 | (1.47) |
| Net Income | (8.75) | (2.63) | (3.17) | (0.94) |
| Net Margin % | (382.1%) | (77.4%) | (64.1%) | (13.7%) |
| Diluted EPS | -$0.53 | -$0.16 | -$0.19 | -$0.06 |
| Basic EPS | -$0.53 | -$0.16 | -$0.19 | -$0.06 |
| Diluted Avg Shares | 16.5 | 16.5 | — | 16.3 |
| Basic Avg Shares | 16.5 | 16.5 | — | 16.3 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Total Revenue | 17.51 | 27.48 | 41.81 | 24.41 | 44.53 |
| Revenue YoY % | (36.3%) | (34.3%) | 71.3% | (45.2%) | — |
| Cost of Revenue | 11.14 | 15.62 | 17.38 | 10.35 | 14.90 |
| Gross Profit | 6.37 | 11.87 | 24.43 | 14.06 | 29.63 |
| Gross Profit YoY % | (46.3%) | (51.4%) | 73.8% | (52.5%) | — |
| Gross Margin % | 36.4% | 43.2% | 58.4% | 57.6% | 66.5% |
| SG&A | 7.51 | 7.87 | 7.15 | 5.16 | 11.34 |
| R&D | 6.40 | 7.78 | 4.22 | 3.68 | 3.46 |
| Operating Expense | 19.62 | 22.17 | 16.34 | 14.44 | 14.80 |
| Operating Income | (13.26) | (10.31) | 8.09 | (0.38) | 14.83 |
| Operating Income YoY % | (28.6%) | (227.4%) | 2217.8% | (102.6%) | — |
| Operating Margin % | (75.7%) | (37.5%) | 19.4% | (1.6%) | 33.3% |
| EBITDA | (12.87) | (9.91) | 8.29 | (0.11) | 15.15 |
| EBITDA Margin % | (73.5%) | (36.0%) | 19.8% | (0.4%) | 34.0% |
| Interest Expense | 0.56 | 0.68 | (0.93) | (0.99) | (0.38) |
| Other Income / (Expense) | 1.11 | 1.37 | — | — | 12.78 |
| Pretax Income | (12.70) | (9.62) | 9.02 | 0.65 | 27.99 |
| Tax Provision | 2.79 | (1.91) | 2.38 | 0.17 | 3.75 |
| Net Income | (15.48) | (7.72) | 6.65 | 0.48 | 24.24 |
| Net Margin % | (88.5%) | (28.1%) | 15.9% | 2.0% | 54.4% |
| Diluted EPS | -$0.94 | -$0.47 | $0.41 | $0.03 | $1.46 |
| Basic EPS | -$0.94 | -$0.47 | $0.41 | $0.03 | $1.47 |
| Diluted Avg Shares | 16.5 | 16.3 | 16.4 | 16.3 | 16.6 |
| Basic Avg Shares | 16.5 | 16.3 | 16.3 | 16.3 | 16.5 |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Cash & Equivalents | 15.19 | 18.33 | 22.08 | 24.45 |
| Receivables | 1.68 | 3.58 | 6.04 | 9.34 |
| Inventory | 18.46 | 16.50 | 14.56 | 13.04 |
| Other Current Assets | 2.35 | 4.18 | 3.21 | 3.38 |
| Total Current Assets | 37.68 | 42.59 | 45.89 | 50.20 |
| Net PPE | 2.75 | 2.31 | 1.98 | 2.52 |
| Operating Lease ROU | 0.33 | 0.39 | 0.45 | 0.51 |
| Other Assets | 0.51 | 6.25 | 4.72 | 5.05 |
| Total Assets | 41.26 | 51.55 | 53.04 | 58.30 |
| Current Lease Liabilities | 0.27 | 0.27 | 0.26 | 0.26 |
| Other Current Liabilities | 4.05 | 5.59 | 4.46 | 6.55 |
| Total Current Liabilities | 4.33 | 5.86 | 4.72 | 6.80 |
| Long-term Lease Liabilities | 0.07 | 0.14 | 0.21 | 0.28 |
| Total Liabilities | 4.40 | 6.00 | 4.94 | 7.10 |
| Retained Earnings | (5.66) | 3.09 | 5.71 | 8.88 |
| Total Equity | 36.86 | 45.54 | 48.10 | 51.19 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 15.19 | 22.08 | 22.06 | 23.15 | 25.52 |
| Receivables | 1.68 | 6.04 | 19.73 | 10.64 | 17.30 |
| Inventory | 18.46 | 14.56 | 10.10 | 11.86 | 3.50 |
| Other Current Assets | 2.35 | 3.21 | 4.85 | 3.87 | 6.92 |
| Total Current Assets | 37.68 | 45.89 | 56.74 | 49.53 | 53.24 |
| Net PPE | 2.75 | 1.98 | 2.00 | 0.46 | 0.24 |
| Operating Lease ROU | 0.33 | 0.45 | 0.58 | 0.77 | 1.00 |
| Intangible Assets | — | — | — | — | 0.05 |
| Other Assets | 0.51 | 4.72 | 2.85 | 2.94 | 2.21 |
| Total Assets | 41.26 | 53.04 | 62.16 | 53.71 | 56.73 |
| Current Lease Liabilities | 0.27 | 0.26 | 0.20 | 0.19 | 0.19 |
| Other Current Liabilities | 4.05 | 4.46 | 5.68 | 4.03 | 7.51 |
| Total Current Liabilities | 4.33 | 4.72 | 5.88 | 4.21 | 7.70 |
| Long-term Lease Liabilities | 0.07 | 0.21 | 0.40 | 0.60 | 0.83 |
| Total Liabilities | 4.40 | 4.94 | 6.34 | 4.87 | 8.67 |
| Retained Earnings | (5.66) | 5.71 | 13.43 | 6.79 | 6.30 |
| Total Equity | 36.86 | 48.10 | 55.83 | 48.84 | 48.07 |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Net Income | (8.75) | (2.63) | (3.17) | (0.94) |
| D&A | 0.09 | 0.10 | 0.10 | 0.10 |
| Stock-Based Comp | 0.07 | 0.07 | 0.08 | 0.07 |
| Δ Working Cap & Other | 5.46 | (1.29) | 0.78 | 3.07 |
| Operating Cash Flow | (3.13) | (3.75) | (2.21) | 2.29 |
| CapEx | (0.01) | (0.00) | (0.16) | (0.00) |
| Investing Cash Flow | (0.01) | (0.00) | (0.16) | (0.00) |
| Stock Buyback | — | — | 0.00 | 0.00 |
| Financing Cash Flow | — | — | (0.01) | 0.00 |
| Free Cash Flow | (3.14) | (3.76) | (2.37) | 2.29 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Net Income | (15.48) | (7.72) | 6.65 | 0.48 | 24.24 |
| D&A | 0.38 | 0.40 | 0.20 | 0.28 | 0.32 |
| Stock-Based Comp | 0.29 | 0.29 | 0.32 | 0.33 | 0.19 |
| Δ Working Cap & Other | 8.02 | 7.55 | (8.00) | (3.23) | (26.16) |
| Operating Cash Flow | (6.80) | 0.53 | (0.83) | (2.15) | (1.41) |
| CapEx | (0.17) | (0.20) | (0.28) | (0.23) | (0.16) |
| Other Investing | — | — | — | — | 15.00 |
| Investing Cash Flow | (0.17) | (0.20) | (0.28) | (0.19) | 14.84 |
| Stock Buyback | — | (0.30) | — | (0.03) | (3.00) |
| Other Financing | — | — | — | — | 0.57 |
| Financing Cash Flow | — | (0.30) | 0.01 | (0.04) | (2.43) |
| Free Cash Flow | (6.97) | 0.33 | (1.11) | (2.37) | (1.57) |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Current Ratio | 8.71 | 7.27 | 9.72 | 7.38 |
| Quick Ratio | 4.44 | 4.45 | 6.63 | 5.46 |
| Debt / Equity | — | — | — | — |
| EBITDA Margin % | (135.1%) | (125.6%) | (61.7%) | (35.9%) |
| Working Capital | 33.35 | 36.73 | 41.17 | 43.40 |
| Net Debt | — | — | — | — |
| ROE % | (23.7%) | (5.8%) | (6.6%) | (1.8%) |
| ROA % | (21.2%) | (5.1%) | (6.0%) | (1.6%) |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Current Ratio | 8.71 | 9.72 | 9.64 | 11.76 | 6.92 |
| Quick Ratio | 4.44 | 6.63 | 7.93 | 8.94 | 6.46 |
| Debt / Equity | — | — | — | — | — |
| EBITDA Margin % | (73.5%) | (36.0%) | 19.8% | (0.4%) | 34.0% |
| Working Capital | 33.35 | 41.17 | 50.85 | 45.32 | 45.54 |
| Net Debt | — | — | — | — | — |
| ROE % | (42.0%) | (16.0%) | 11.9% | 1.0% | 50.4% |
| ROA % | (37.5%) | (14.6%) | 10.7% | 0.9% | 42.7% |
Insider activity (last 2 years)
| Date Filed | Reporter | Relationship | Trans. Date | Code | Shares | Price | Total Value |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Sachetta Eric | Director | 2026-08-31 | P | 27,304 | $3.54 | $96,602 |
| 2026-08-31 | Sachetta Eric | Director | 2026-08-28 | P | 37,537 | $3.44 | $129,015 |
| 2026-08-28 | Sachetta Eric | Director | 2026-08-27 | P | 10,925 | $3.18 | $34,752 |
| 2026-08-28 | Sachetta Eric | Director | 2026-08-26 | P | 9,708 | $3.29 | $31,930 |
| 2026-08-25 | Sachetta Eric | Director | 2026-08-24 | P | 34,697 | $3.25 | $112,904 |
| 2026-08-24 | Sachetta Eric | Director | 2026-08-21 | P | 7,000 | $3.25 | $22,778 |
| 2026-08-24 | Sardano Joseph C | Director, Officer (CHIEF EXECUTIVE OFFICER) | 2026-08-20 | P | 20,000 | $3.02 | $60,486 |
| 2026-08-24 | Sachetta Eric | Director | 2026-08-20 | P | 24,000 | $3.13 | $75,072 |
| 2026-05-12 | Sachetta Eric | Director | 2026-05-12 | P | 1,500 | $3.33 | $5,002 |
| 2026-04-22 | Martinez Magdalena | Officer (CHIEF OPERATING OFFICER) | 2023-12-19 | F | (741) | $2.66 | -$1,971 |
| 2026-04-22 | Rampolla Javier | Officer (CHIEF FINANCIAL OFFICER) | 2022-07-21 | F | (3,935) | $10.51 | -$41,357 |
| 2026-02-26 | Sachetta Eric | Director | 2026-02-24 | P | 2,000 | $3.81 | $7,620 |
| 2025-12-16 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-12-12 | A | 40,000 | — | $0 |
| 2025-11-21 | Sachetta Eric | Director | 2025-11-21 | P | 7,000 | $3.93 | $27,510 |
| 2025-11-20 | Sachetta Eric | Director | 2025-11-13 | P | 2,500 | $4.50 | $11,250 |
| 2025-11-19 | Sardano Joseph C | Director, Officer (CHIEF EXECUTIVE OFFICER) | 2025-11-18 | P | 25,000 | $4.03 | $100,750 |
| 2025-11-19 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-18 | P | 1,000 | $3.80 | $3,800 |
| 2025-11-18 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-11 | P | 1,000 | $4.26 | $4,260 |
| 2025-11-18 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-11 | P | 766 | $4.27 | $3,271 |
| 2025-11-18 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-11 | P | 234 | $4.34 | $1,016 |
| 2025-11-13 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-11 | P | 1,000 | $4.26 | $4,260 |
| 2025-11-13 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-11 | P | 766 | $4.27 | $3,271 |
| 2025-11-13 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-11 | P | 234 | $4.24 | $992 |
| 2025-11-12 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-11-11 | P | 1,000 | $4.26 | $4,260 |
| 2025-08-14 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-08-13 | P | 1,000 | $3.37 | $3,370 |
| 2025-02-10 | Rampolla Javier | Officer (CHIEF FINANCIAL OFFICER) | 2025-02-10 | P | 501 | $5.95 | $2,981 |
| 2025-02-10 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2025-02-10 | P | 1,000 | $5.95 | $5,950 |
| 2024-12-19 | Petrelli Anthony Benedict | Director | 2024-12-17 | A | 20,000 | — | $0 |
| 2024-12-19 | McCall William H | Director | 2024-12-17 | A | 20,000 | — | $0 |
| 2024-12-19 | Cornish Megan | Director | 2024-12-17 | A | 20,000 | — | $0 |
| 2024-12-19 | Sardano Michael | Director, Officer (PRESIDENT AND GENERAL COUNSEL) | 2024-12-17 | A | 40,000 | — | $0 |